USD 83.18
(-0.1%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 69.04 Billion USD | 9.41% |
2022 | 63.1 Billion USD | -6.43% |
2021 | 67.43 Billion USD | 1.89% |
2020 | 66.18 Billion USD | 13.34% |
2019 | 58.39 Billion USD | 4.74% |
2018 | 55.75 Billion USD | 4.6% |
2017 | 53.3 Billion USD | -3.21% |
2016 | 55.06 Billion USD | -3.41% |
2015 | 57.01 Billion USD | 15.07% |
2014 | 49.54 Billion USD | -7.08% |
2013 | 53.31 Billion USD | 5.23% |
2012 | 50.66 Billion USD | 5.16% |
2011 | 48.18 Billion USD | -1.62% |
2010 | 48.97 Billion USD | -3.2% |
2009 | 50.59 Billion USD | 94.39% |
2008 | 26.02 Billion USD | -6.23% |
2007 | 27.75 Billion USD | 12.82% |
2006 | 24.6 Billion USD | 0.33% |
2005 | 24.52 Billion USD | 7.19% |
2004 | 22.87 Billion USD | 8.45% |
2003 | 21.09 Billion USD | -13.66% |
2002 | 24.43 Billion USD | 5.68% |
2001 | 23.11 Billion USD | 15.27% |
2000 | 20.05 Billion USD | 5.94% |
1999 | 18.93 Billion USD | 23.37% |
1998 | 15.34 Billion USD | 27.74% |
1997 | 12.01 Billion USD | 19.99% |
1996 | 10.01 Billion USD | 2.07% |
1995 | 9.8 Billion USD | 3.17% |
1994 | 9.5 Billion USD | 8.53% |
1993 | 8.76 Billion USD | 60.58% |
1992 | 5.45 Billion USD | 36.82% |
1991 | 3.98 Billion USD | 9.37% |
1990 | 3.64 Billion USD | 33.74% |
1989 | 2.72 Billion USD | -16.67% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 65.42 Billion USD | -5.24% |
2024 Q2 | 68.98 Billion USD | 5.44% |
2023 Q1 | 60.89 Billion USD | -3.5% |
2023 Q3 | 65.42 Billion USD | -0.46% |
2023 Q2 | 65.72 Billion USD | 7.94% |
2023 FY | 69.04 Billion USD | 9.41% |
2023 Q4 | 69.04 Billion USD | 5.52% |
2022 Q3 | 62.55 Billion USD | -1.91% |
2022 Q2 | 63.77 Billion USD | -2.95% |
2022 Q4 | 63.1 Billion USD | 0.87% |
2022 Q1 | 65.71 Billion USD | -2.55% |
2022 FY | 63.1 Billion USD | -6.43% |
2021 FY | 67.43 Billion USD | 1.89% |
2021 Q4 | 67.43 Billion USD | 17.02% |
2021 Q3 | 57.63 Billion USD | 0.58% |
2021 Q2 | 57.3 Billion USD | -10.2% |
2021 Q1 | 63.8 Billion USD | -3.59% |
2020 Q4 | 66.18 Billion USD | 9.34% |
2020 Q3 | 60.53 Billion USD | -3.72% |
2020 Q2 | 62.87 Billion USD | 7.26% |
2020 Q1 | 58.61 Billion USD | 0.37% |
2020 FY | 66.18 Billion USD | 13.34% |
2019 Q4 | 58.39 Billion USD | 3.53% |
2019 Q1 | 54.68 Billion USD | -1.92% |
2019 Q3 | 56.4 Billion USD | 0.32% |
2019 Q2 | 56.22 Billion USD | 2.82% |
2019 FY | 58.39 Billion USD | 4.74% |
2018 Q3 | 52.47 Billion USD | 0.38% |
2018 FY | 55.75 Billion USD | 4.6% |
2018 Q4 | 55.75 Billion USD | 6.25% |
2018 Q2 | 52.27 Billion USD | 0.26% |
2018 Q1 | 52.14 Billion USD | -2.18% |
2017 FY | 53.3 Billion USD | -3.21% |
2017 Q1 | 56.47 Billion USD | 2.55% |
2017 Q2 | 53.09 Billion USD | -5.99% |
2017 Q3 | 53.17 Billion USD | 0.16% |
2017 Q4 | 53.3 Billion USD | 0.24% |
2016 Q3 | 54.37 Billion USD | 2.54% |
2016 Q1 | 54.85 Billion USD | -3.79% |
2016 FY | 55.06 Billion USD | -3.41% |
2016 Q2 | 53.02 Billion USD | -3.33% |
2016 Q4 | 55.06 Billion USD | 1.27% |
2015 Q1 | 60.42 Billion USD | 21.97% |
2015 Q2 | 55.94 Billion USD | -7.42% |
2015 Q3 | 55.55 Billion USD | -0.7% |
2015 Q4 | 57.01 Billion USD | 2.63% |
2015 FY | 57.01 Billion USD | 15.07% |
2014 Q3 | 56.44 Billion USD | 14.4% |
2014 Q4 | 49.54 Billion USD | -12.23% |
2014 FY | 49.54 Billion USD | -7.08% |
2014 Q1 | 55.89 Billion USD | 4.83% |
2014 Q2 | 49.34 Billion USD | -11.72% |
2013 Q4 | 53.31 Billion USD | -5.48% |
2013 FY | 53.31 Billion USD | 5.23% |
2013 Q3 | 56.41 Billion USD | -0.63% |
2013 Q1 | 50.59 Billion USD | -0.15% |
2013 Q2 | 56.77 Billion USD | 12.21% |
2012 Q4 | 50.66 Billion USD | 5.37% |
2012 FY | 50.66 Billion USD | 5.16% |
2012 Q1 | 48.19 Billion USD | 0.02% |
2012 Q2 | 47.85 Billion USD | -0.71% |
2012 Q3 | 48.08 Billion USD | 0.5% |
2011 Q4 | 48.18 Billion USD | -1.54% |
2011 Q1 | 49.02 Billion USD | 0.1% |
2011 Q2 | 48.27 Billion USD | -1.54% |
2011 Q3 | 48.93 Billion USD | 1.38% |
2011 FY | 48.18 Billion USD | -1.62% |
2010 Q1 | 51.25 Billion USD | 1.29% |
2010 FY | 48.97 Billion USD | -3.2% |
2010 Q3 | 52.24 Billion USD | 7.72% |
2010 Q4 | 48.97 Billion USD | -6.26% |
2010 Q2 | 48.5 Billion USD | -5.36% |
2009 FY | 50.59 Billion USD | 94.39% |
2009 Q4 | 50.59 Billion USD | -4.12% |
2009 Q3 | 52.77 Billion USD | 97.87% |
2009 Q2 | 26.67 Billion USD | 8.67% |
2009 Q1 | 24.54 Billion USD | -5.71% |
2008 Q1 | 25.08 Billion USD | -9.64% |
2008 Q4 | 26.02 Billion USD | -1.91% |
2008 Q3 | 26.53 Billion USD | 7.03% |
2008 Q2 | 24.79 Billion USD | -1.16% |
2008 FY | 26.02 Billion USD | -6.23% |
2007 Q1 | 22.07 Billion USD | -10.27% |
2007 Q4 | 27.75 Billion USD | 23.15% |
2007 Q3 | 22.54 Billion USD | 1.07% |
2007 Q2 | 22.3 Billion USD | 1.02% |
2007 FY | 27.75 Billion USD | 12.82% |
2006 Q4 | 24.6 Billion USD | 11.85% |
2006 Q2 | 21.77 Billion USD | -1.64% |
2006 FY | 24.6 Billion USD | 0.33% |
2006 Q1 | 22.13 Billion USD | -9.73% |
2006 Q3 | 21.99 Billion USD | 1.03% |
2005 FY | 24.52 Billion USD | 7.19% |
2005 Q1 | 23.03 Billion USD | 0.67% |
2005 Q2 | 23.21 Billion USD | 0.78% |
2005 Q3 | 23.61 Billion USD | 1.73% |
2005 Q4 | 24.52 Billion USD | 3.84% |
2004 Q4 | 22.87 Billion USD | 5.79% |
2004 Q2 | 20.97 Billion USD | -2.25% |
2004 Q3 | 21.62 Billion USD | 3.12% |
2004 Q1 | 21.45 Billion USD | 1.71% |
2004 FY | 22.87 Billion USD | 8.45% |
2003 Q1 | 26.01 Billion USD | 6.5% |
2003 Q2 | 26.35 Billion USD | 1.31% |
2003 Q3 | 23.2 Billion USD | -11.96% |
2003 FY | 21.09 Billion USD | -13.66% |
2003 Q4 | 21.09 Billion USD | -9.1% |
2002 Q4 | 24.43 Billion USD | -1.85% |
2002 Q2 | 24.21 Billion USD | 0.17% |
2002 FY | 24.43 Billion USD | 5.68% |
2002 Q1 | 24.17 Billion USD | 4.58% |
2002 Q3 | 24.89 Billion USD | 2.79% |
2001 Q4 | 23.11 Billion USD | -1.24% |
2001 Q3 | 23.4 Billion USD | 6.28% |
2001 Q2 | 22.02 Billion USD | 7.72% |
2001 Q1 | 20.44 Billion USD | 1.95% |
2001 FY | 23.11 Billion USD | 15.27% |
2000 Q3 | 19.47 Billion USD | -1.23% |
2000 FY | 20.05 Billion USD | 5.94% |
2000 Q4 | 20.05 Billion USD | 3.0% |
2000 Q2 | 19.71 Billion USD | 5.54% |
2000 Q1 | 18.67 Billion USD | -1.34% |
1999 Q4 | 18.93 Billion USD | 5.98% |
1999 Q1 | 15.22 Billion USD | -0.82% |
1999 FY | 18.93 Billion USD | 23.37% |
1999 Q2 | 16.52 Billion USD | 8.55% |
1999 Q3 | 17.86 Billion USD | 8.13% |
1998 Q2 | 12.64 Billion USD | 5.12% |
1998 FY | 15.34 Billion USD | 27.74% |
1998 Q1 | 12.02 Billion USD | 0.12% |
1998 Q3 | 14.95 Billion USD | 18.27% |
1998 Q4 | 15.34 Billion USD | 2.62% |
1997 Q1 | 10.08 Billion USD | 0.71% |
1997 Q2 | 10.51 Billion USD | 4.27% |
1997 Q3 | 11.82 Billion USD | 12.49% |
1997 Q4 | 12.01 Billion USD | 1.57% |
1997 FY | 12.01 Billion USD | 19.99% |
1996 Q2 | 9.6 Billion USD | -4.27% |
1996 Q4 | 10.01 Billion USD | -2.47% |
1996 Q3 | 10.26 Billion USD | 6.88% |
1996 Q1 | 10.03 Billion USD | 2.28% |
1996 FY | 10.01 Billion USD | 2.07% |
1995 Q3 | 9.65 Billion USD | 6.01% |
1995 Q4 | 9.8 Billion USD | 1.6% |
1995 FY | 9.8 Billion USD | 3.17% |
1995 Q1 | 9.37 Billion USD | -1.42% |
1995 Q2 | 9.1 Billion USD | -2.84% |
1994 FY | 9.5 Billion USD | 8.53% |
1994 Q1 | 8.35 Billion USD | -4.63% |
1994 Q2 | 8.59 Billion USD | 2.82% |
1994 Q3 | 8.6 Billion USD | 0.17% |
1994 Q4 | 9.5 Billion USD | 10.5% |
1993 FY | 8.76 Billion USD | 60.58% |
1993 Q2 | 6.67 Billion USD | 17.06% |
1993 Q4 | 8.76 Billion USD | 39.48% |
1993 Q1 | 5.7 Billion USD | 4.58% |
1993 Q3 | 6.28 Billion USD | -5.96% |
1992 FY | 5.45 Billion USD | 36.82% |
1992 Q2 | 4.22 Billion USD | 6.47% |
1992 Q4 | 5.45 Billion USD | 13.6% |
1992 Q3 | 4.8 Billion USD | 13.6% |
1992 Q1 | 3.97 Billion USD | -0.42% |
1991 Q1 | 3.68 Billion USD | 0.98% |
1991 Q2 | 3.73 Billion USD | 1.35% |
1991 Q3 | 3.97 Billion USD | 6.6% |
1991 Q4 | 3.98 Billion USD | 0.25% |
1991 FY | 3.98 Billion USD | 9.37% |
1990 Q4 | 3.64 Billion USD | 4.08% |
1990 Q2 | 3.18 Billion USD | 8.39% |
1990 Q1 | 2.93 Billion USD | 7.7% |
1990 Q3 | 3.5 Billion USD | 10.08% |
1990 FY | 3.64 Billion USD | 33.74% |
1989 Q4 | 2.72 Billion USD | 2.4% |
1989 Q3 | 2.66 Billion USD | 0.0% |
1989 FY | 2.72 Billion USD | -16.67% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AbbVie Inc. | 124.31 Billion USD | 44.463% |
Bristol-Myers Squibb Company | 65.67 Billion USD | -5.125% |
Bristol-Myers Squibb Company Ce | 65.67 Billion USD | -5.125% |
Johnson & Johnson | 98.78 Billion USD | 30.11% |
Eli Lilly and Company | 53.14 Billion USD | -29.915% |
Novartis AG | 53.19 Billion USD | -29.787% |
Organon & Co. | 12.12 Billion USD | -469.261% |
Pfizer Inc. | 137.21 Billion USD | 49.684% |